1. Home
  2. SABS vs HUBC Comparison

SABS vs HUBC Comparison

Compare SABS & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • HUBC
  • Stock Information
  • Founded
  • SABS 2014
  • HUBC 2017
  • Country
  • SABS United States
  • HUBC Israel
  • Employees
  • SABS N/A
  • HUBC N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • SABS Health Care
  • HUBC
  • Exchange
  • SABS Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • SABS 31.2M
  • HUBC 32.0M
  • IPO Year
  • SABS N/A
  • HUBC N/A
  • Fundamental
  • Price
  • SABS $3.06
  • HUBC $1.37
  • Analyst Decision
  • SABS Strong Buy
  • HUBC
  • Analyst Count
  • SABS 3
  • HUBC 0
  • Target Price
  • SABS $9.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • SABS 261.4K
  • HUBC 608.0K
  • Earning Date
  • SABS 11-06-2025
  • HUBC 05-01-2026
  • Dividend Yield
  • SABS N/A
  • HUBC N/A
  • EPS Growth
  • SABS N/A
  • HUBC N/A
  • EPS
  • SABS N/A
  • HUBC N/A
  • Revenue
  • SABS $114,698.00
  • HUBC $29,562,000.00
  • Revenue This Year
  • SABS N/A
  • HUBC N/A
  • Revenue Next Year
  • SABS N/A
  • HUBC N/A
  • P/E Ratio
  • SABS N/A
  • HUBC N/A
  • Revenue Growth
  • SABS N/A
  • HUBC N/A
  • 52 Week Low
  • SABS $1.00
  • HUBC $1.33
  • 52 Week High
  • SABS $6.60
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • SABS 59.76
  • HUBC 35.88
  • Support Level
  • SABS $2.93
  • HUBC $1.33
  • Resistance Level
  • SABS $3.34
  • HUBC $1.46
  • Average True Range (ATR)
  • SABS 0.23
  • HUBC 0.13
  • MACD
  • SABS 0.01
  • HUBC 0.01
  • Stochastic Oscillator
  • SABS 61.69
  • HUBC 7.68

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: